Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market
This report contains market size and forecasts of Non-Peptide Drugs of Angiotensin II Receptor An ... Read More
This report contains market size and forecasts of Etodolac in global, including the following market information:
Global Etodolac Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Etodolac Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Etodolac companies in 2021 (%)
The global Etodolac market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Etodolac include Amneal Pharmaceuticals, Genpharm Ulc, Physicians Total Care, Actavis Elizabeth , Blenheim Pharmacal, Teva , Taro Pharmaceuticals , Apotex and PD-Rx Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Etodolac manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Etodolac Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Etodolac Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsules
Global Etodolac Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Etodolac Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Osteoarthritis
Mild to Moderate Pain
Other
Global Etodolac Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Etodolac Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Etodolac revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Etodolac revenues share in global market, 2021 (%)
Key companies Etodolac sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Etodolac sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amneal Pharmaceuticals
Genpharm Ulc
Physicians Total Care
Actavis Elizabeth
Blenheim Pharmacal
Teva
Taro Pharmaceuticals
Apotex
PD-Rx Pharmaceuticals
Nucare Pharmaceuticals
Eon Labs
This report contains market size and forecasts of Non-Peptide Drugs of Angiotensin II Receptor An ... Read More
This report contains market size and forecasts of Allisartan Isoproxil in global, including the f ... Read More
This report contains market size and forecasts of Apatinib in global, including the following mar ... Read More
This report contains market size and forecasts of PD-1 Inhibitor in Global, including the followi ... Read More